Page 5 - Patrick Wingrove News Today

NEW YORK (Reuters) -Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 drugs in early January, according to data analyzed by healthcare research firm 3 Axis Advisors. The expected price hikes come as the pharmaceutical industry gears up for the Biden Administration to publish significantly discounted prices for 10 high-cost drugs in September, and continues to contend with higher inflation and manufacturing costs. Under Pres...

By Michael Erman and Patrick Wingrove NEW YORK (Reuters) - Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the U...

By Michael Erman and Patrick Wingrove NEW YORK (Reuters) - Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the U...

By Michael Erman and Patrick Wingrove NEW YORK (Reuters) - Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the U...

By Michael Erman and Patrick Wingrove NEW YORK (Reuters) - Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the U...

By Michael Erman and Patrick Wingrove NEW YORK (Reuters) - Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the U...

By Michael Erman and Patrick Wingrove NEW YORK (Reuters) - Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the U...

By Michael Erman and Patrick Wingrove NEW YORK (Reuters) - Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the U...

(Reuters) - Novo Nordisk has sued one compounding pharmacy and refiled a lawsuit against another after finding their products claiming to contain the

U.S. drug regulators in September found quality control lapses at Modernas main factory including with equipment used to manufacture drug substance for its COVID-19 vaccine, according to the report obtained by Reuters via a Freedom of Information Act request.